According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening the door to cheaper generic copycats, after the drug giant reportedly ...

Adding this $4 vegetable to your diet may help you lose weight, prevent high blood sugar levels and brain inflammation, a study suggests.

In an about-face, the administration is cracking down on so-called skin substitutes, overused treatments that cost Medicare ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...

Ozempic has taken the world by storm as a weight-loss and diabetes drug—but what’s the full story? In this eye-opening ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...